Shocking Percent of Physicians Still Smoking

Article

Healthcare providers are supposed to be one of the top advocates for no smoking, right? Well the amount of physicians still lighting up cigarettes is prevalent.

Healthcare providers are supposed to be one of the top advocates for no smoking, right? Well the amount of physicians still lighting up cigarettes is prevalent.

Angelo T. Adraneda, MD, from the Chinese General Hospital in the Philippines, and colleagues aimed to find how many physicians going through specialty training are smoking. The data will be presented during a poster session at CHEST 2015 in Montréal, Canada.

The team looked at 557 physicians in specialty training in Manila, Philippines. They filled out questionnaires developed from the World Health Organization’s (WHO) Global Health Professional Survey and The Wisconsin Inventory of Smoking Dependence Motives (WISDM-68).

On a high note, the majority of the physicians (57.45%) in the study reported never being smokers. However, too many revealed that they are current smokers (27.83%). Of those, physicians in specialty training for surgery proved to have the most smokers (39.62%).

Specialty training is a major factor contributing the high statistics, according to the report. Although a lesser major factor, duty hours are also a contributor.

“Data collected showed that those with family members, immediate superiors, and colleagues who smoke are more likely to smoke as well,” the team pointed out.

This is one practice that no doctor, or person for that matter, should start or continue.

“Hopefully, with the results of this study, it could help reduce the number of smokers or cigarette consumption by improving work schedules among these health care professionals — making them worthy promoters of smoking cessation programs,” the researchers concluded.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.